WVE Projected Dividend Yield
Ord/Wave Life Sciences Ltd ( NASDAQ : WVE )Wave Life Sciences is a clinical-stage genetic medicines company. Co. has a pipeline of programs. Co.'s primary programs are designed to treat genetic diseases, which include: WVE-N531 (splicing), its exon 53 molecule for the treatment of Duchenne muscular dystrophy; WVE-006 (editing), its SERPINA1 molecule for the treatment of alpha-1 antitrypsin deficiency; WVE-003 (silencing), its mutant huntingtin single nucleotide polymorphism three molecule for the treatment of Huntington's disease; and WVE-004 (silencing), its C9orf72 molecule for the treatment of C9orf72-associated amyotrophic lateral sclerosis and frontotemporal dementia. 20 YEAR PERFORMANCE RESULTS |
WVE Dividend History Detail WVE Dividend News WVE Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |